Terizidone

ANTIINFECTIVES FOR SYSTEMIC USE

Key facts

Terizidone is a drug catalogued in DrugCentral.

• ATC code: J04AK03 (Other drugs for treatment of tuberculosis).
• Molecular formula: C14H14N4O4; molecular weight 302.29 g/mol.

ATC classification

ATC code	Therapeutic hierarchy
J04AK03	ANTIINFECTIVES FOR SYSTEMIC USE › ANTIMYCOBACTERIALS › DRUGS FOR TREATMENT OF TUBERCULOSIS › Other drugs for treatment of tuberculosis

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA term	LLR
Electrocardiogram QT prolonged	138.7
Drug resistance	132.1
Polyneuropathy	117.1
Myelosuppression	106.0
Neuropathy peripheral	81.4
Anaemia	76.8
Bicytopenia	59.3
Psychotic disorder	56.9

Chemical structure

• Molecular formula: C₁₄H₁₄N₄O₄
• Molecular weight: 302.29 g/mol
• CAS number: 25683-71-0
• InChIKey: ODKYYBOHSVLGNU-IAGONARPSA-N
• PubChem CID: 65720

O=C1NOCC1\N=C\C1=CC=C(\C=N\C2CONC2=O)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is the chemical formula of Terizidone?

Terizidone has the molecular formula C14H14N4O4 and a molecular weight of 302.29 g/mol.

Sources

• DrugCentral drug card 2602 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL2107553 — compound record and bioactivity
• PubChem CID 65720 — chemical identifiers
• DrugBank DB12954 — drug record
• FDA UNII 1199LEX5N8 — substance identity
• FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral

How this page is built: methodology · editorial policy & corrections.